Trial intelligence / Profile preview

RPM: Combination Risedronate and Teriparatide in Male Osteoporosis

NCT01611571Phase 3Completed

Sponsor
Columbia University
Start
Dec 2003
Primary completion
Nov 2011
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of risedronate, teriparatide in osteoporosis, sponsored by Columbia University. Started Dec 2003; status: completed.

02

Drugs

risedronateteriparatide
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT01611571.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01611571.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call